{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:48:55Z","timestamp":1779893335438,"version":"3.53.1"},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endoscopy"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>\n            Background\u2002The goals of therapy for patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease include weight loss and reduction of the portosystemic pressure gradient (PPG) to decrease the risk of hepatic decompensation. Endoscopic gastric plication (EGP) is an effective endoscopic weight loss procedure. This study aimed to assess the effect of EGP on PPG.<\/jats:p><jats:p>\n            Methods\u2002In this prospective pilot study, patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease underwent endoscopic ultrasound-guided PPG measurement prior to and at 6 months following EGP. Primary outcomes were the change in PPG and proportion of patients experiencing \u2265\u200a20\u200a% reduction in PPG at 6 months. Secondary outcomes included percent total weight loss (TWL) and changes in noninvasive tests of fibrosis. <\/jats:p><jats:p>\n            Results\u200220 patients were included. Baseline median body mass index and liver stiffness measurement were 40.2\u200akg\/m2 (range 30.1\u201356.7) and 14.7 kPa (range 8.2\u201336), respectively. At 6 months, median PPG decreased from 5.4\u200ammHg (range 0.7\u201319.6) to 1.8\u200ammHg (range 0.4\u201317.6) (P\u200a=\u200a0.002), with 79\u200a% (11\/14) experiencing \u2265\u200a20\u200a% reduction. Patients experienced 12.5\u200a% (6.5\u200a%\u201326.1\u200a%) TWL (P\u200a&lt;\u200a0.001) at 6 months, with 89\u200a% (17\/19) achieving \u2265\u200a7\u200a% and 68\u200a% (13\/19) achieving \u2265\u200a10\u200a% TWL. There were significant improvements in noninvasive tests of fibrosis.<\/jats:p><jats:p>\n            Conclusion\u2002EGP appeared to be effective at reducing PPG in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease.<\/jats:p>","DOI":"10.1055\/a-2146-8857","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T23:12:25Z","timestamp":1691017945000},"page":"56-62","source":"Crossref","is-referenced-by-count":12,"title":["The effect of endoscopic gastric plication on portosystemic pressure gradient in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease"],"prefix":"10.1055","volume":"56","clinical-trial-number":[{"clinical-trial-number":"nct04820036","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5273-6851","authenticated-orcid":false,"given":"Pichamol","family":"Jirapinyo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States"},{"name":"Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-5270","authenticated-orcid":false,"given":"Christopher C.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States"},{"name":"Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[{"name":"Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, United States"},{"name":"Section of Digestive Diseases, VA-CT Healthcare System, West Haven, Connecticut, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Zucker","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States"},{"name":"Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Ryou","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States"},{"name":"Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Z Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"E Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S000711451800137X","article-title":"Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial","volume":"120","author":"C N Katsagoni","year":"2018","journal-title":"Br J Nutr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.28992","article-title":"Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study","volume":"65","author":"A Berzigotti","year":"2017","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cgh.2016.10.021","article-title":"Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action","volume":"15","author":"P Jirapinyo","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.14309\/ajg.0000000000001200","article-title":"Obesity primer for the practicing gastroenterologist","volume":"116","author":"P Jirapinyo","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cgh.2019.08.022","article-title":"Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis","volume":"18","author":"A Hedjoudje","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.cgh.2020.09.055","article-title":"Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity","volume":"19","author":"R Z Sharaiha","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2022.04.093","article-title":"A comparison of distal POSE techniques for the treatment of obesity","author":"P Jirapinyo","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.14309\/ajg.0000000000002087","article-title":"Regression of hepatic fibrosis following endoscopic gastric plication in nonalcoholic fatty liver disease","volume":"118","author":"P Jirapinyo","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"F E M\u00f3zes","year":"2022","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"V W-S Wong","year":"2010","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"G D\u2019Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"D Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.06.013","article-title":"AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD","author":"G Pennisi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"P N Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.gie.2009.10.027","article-title":"A lexicon for endoscopic adverse events: report of an ASGE workshop","volume":"71","author":"P B Cotton","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2020.10.003","article-title":"Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis","volume":"74","author":"J Ferrusqu\u00eda-Acosta","year":"2021","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study","volume":"76","author":"M E Rinella","year":"2022","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2018.09.021","article-title":"Factors associated with histologic response in adult patients with nonalcoholic steatohepatitis","volume":"156","author":"R Loomba","year":"2019","journal-title":"Gastroenterology"},{"key":"ref21","first-page":"159","article-title":"Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?","volume":"7","author":"J L Chin","year":"2016","journal-title":"Front Pharmacol"}],"container-title":["Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2146-8857.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T23:32:17Z","timestamp":1703201537000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2146-8857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":21,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2023,12,21]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2146-8857","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0013-726X","1438-8812"],"issn-type":[{"value":"0013-726X","type":"print"},{"value":"1438-8812","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,2]]},"published":{"date-parts":[[2023,8,2]]}}}